Wall Street brokerages expect that Acadia Healthcare Company Inc (NASDAQ:ACHC) will report earnings per share (EPS) of $0.65 for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Acadia Healthcare’s earnings. The lowest EPS estimate is $0.59 and the highest is $0.68. Acadia Healthcare reported earnings per share of $0.58 during the same quarter last year, which suggests a positive year over year growth rate of 12.1%. The business is expected to issue its next earnings report on Tuesday, October 23rd.

On average, analysts expect that Acadia Healthcare will report full-year earnings of $2.53 per share for the current year, with EPS estimates ranging from $2.40 to $2.60. For the next year, analysts anticipate that the business will post earnings of $2.76 per share, with EPS estimates ranging from $2.44 to $2.90. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Monday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.70. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company had revenue of $765.70 million during the quarter, compared to the consensus estimate of $767.93 million. During the same quarter in the prior year, the firm posted $0.66 earnings per share. The firm’s revenue was up 5.5% compared to the same quarter last year.

Several research analysts have recently issued reports on the company. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 price objective for the company in a research note on Tuesday, July 24th. BidaskClub downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. ValuEngine downgraded Acadia Healthcare from a “sell” rating to a “strong sell” rating in a research note on Friday, June 29th. Credit Suisse Group upped their price objective on Acadia Healthcare from $40.00 to $44.00 and gave the company a “neutral” rating in a research note on Tuesday, July 31st. Finally, Jefferies Financial Group upped their price objective on Acadia Healthcare from $44.00 to $47.00 and gave the company a “buy” rating in a research note on Tuesday, July 31st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $44.29.

Acadia Healthcare stock opened at $38.55 on Tuesday. Acadia Healthcare has a 1 year low of $26.92 and a 1 year high of $52.83. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market capitalization of $3.40 billion, a PE ratio of 16.76, a PEG ratio of 1.19 and a beta of 0.55.

In other Acadia Healthcare news, Director Reeve B. Waud sold 8,135 shares of the stock in a transaction that occurred on Thursday, July 26th. The shares were sold at an average price of $45.00, for a total transaction of $366,075.00. Following the completion of the sale, the director now owns 14,213 shares of the company’s stock, valued at approximately $639,585. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.50% of the company’s stock.

Large investors have recently added to or reduced their stakes in the business. Alpine Woods Capital Investors LLC acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $153,000. New Jersey Better Educational Savings Trust acquired a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $205,000. Bbva Compass Bancshares Inc. acquired a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $259,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $255,000. Finally, Xact Kapitalforvaltning AB acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth approximately $231,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Article: Short Selling Stocks and Day Traders

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.